Brokers Set Expectations for Radius Health, Inc.'s FY2017 Earnings (NASDAQ:RDUS)

Cantor Fitzgerald also issued estimates for Radius Health's FY2018 earnings at ($3.91) EPS.

Several other research firms have also recently commented on RDUS. Canaccord Genuity set a $85.00 target price on shares of Radius Health and gave the stock a "buy" rating in a research report on Monday, July 31st. Zacks Investment Research downgraded shares of Radius Health from a "hold" rating to a "sell" rating in a report on Wednesday, October 4th. The stock of Radius Health Inc (NASDAQ:RDUS) earned "Outperform" rating by Cowen & Co on Friday, May 6. Cantor Fitzgerald reissued a "buy" rating and set a $58.00 price target on shares of Radius Health in a report on Friday, November 3rd. Btg Pactual Global Asset holds 0.21% of its portfolio in Radius Health Inc (NASDAQ:RDUS) for 16,195 shares. Two analysts have rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the company. Radius Health has an average rating of "Hold" and an average price target of $51.00.

TRADEMARK VIOLATION NOTICE: This news story was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. and global trademark and copyright legislation. More interesting news about Radius Health Inc (NASDAQ:RDUS) were released by: Seekingalpha.com and their article: "Radius Health's (RDUS) CEO Jesper Høiland on Q3 2017 Results - Earnings Call ..." published on November 03, 2017 as well as Globenewswire.com's news article titled: "Radius Health Receives FDA Fast Track Designation for Elacestrant (RAD1901)" with publication date: October 18, 2017. The stock increased 4.51% or $1.21 during the last trading session, reaching $28.04. The biopharmaceutical company reported ($1.31) earnings per share for the quarter, missing the Zacks' consensus estimate of ($1.28) by ($0.03).

Radius Health, Inc. has a 12-month low of $24.66 and a 12-month high of $55.30. The company has a debt-to-equity ratio of 0.53, a current ratio of 12.87 and a quick ratio of 12.79.

Radius Health Inc (NASDAQ:RDUS) has risen 9.02% since November 18, 2016 and is uptrending. They expect $-1.40 EPS, down 14.75% or $0.18 from last year's $-1.22 per share. The company had revenue of $13.50 million for the quarter, compared to analyst estimates of $6.90 million. Major shareholders that own at least 10% of a company's stock are required to disclose their sales and purchases with the SEC. The shares were purchased at an average cost of $29.15 per share, for a total transaction of $1,457,500.00.

Goldman Sachs Group Inc, which manages about $386.49B US Long portfolio, upped its stake in Cliffs Nat Res Inc (NYSE:CLF) by 2.47M shares to 3.13M shares, valued at $21.65 million in 2017Q2, according to the filing. Weiss Multi invested in 39,500 shares or 0.08% of the stock. The disclosure for this purchase can be found here.

A number of research firms have recently issued reports on RDUS. Ameritas Investment Partners Inc. boosted its position in shares of Radius Health by 19.9% during the second quarter. Principal Financial Group Inc. now owns 5,970 shares of the biopharmaceutical company's stock valued at $231,000 after buying an additional 180 shares during the last quarter. Cubist Systematic Strategies LLC acquired a new position in shares of Radius Health during the third quarter worth about $110,000. Sei Investments Co. raised its position in shares of Radius Health by 27.7% in the second quarter. Vanguard Group Inc. now owns 3,010,646 shares of the biopharmaceutical company's stock worth $116,362,000 after acquiring an additional 93,188 shares during the period. Farallon Capital Management Llc, a California-based fund reported 3.69 million shares.#img1#. During the same period in the previous year, the company earned ($1.07) EPS. analysts predict that Radius Health, Inc. will post -5.4 EPS for the current fiscal year. BlackRock Inc. now owns 2,630,745 shares of the biopharmaceutical company's stock worth $101,679,000 after purchasing an additional 2,628,070 shares in the last quarter.

Artal Group Sa decreased Radius Health Inc (RDUS) stake by 40% reported in 2017Q2 SEC filing. The Firm is focused on the developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases.

Notícias recomendadas

  • GrubHub Inc. (GRUB) CEO Sells $84798.00 in Stock

    Highbridge Capital Management LLC bought a new position in shares of GrubHub during the 3rd quarter valued at $230,000. The company had revenue of $163.10 million for the quarter, compared to analysts' expectations of $159.63 million.
    How the Roy Moore Sexual Misconduct Scandal Has Evolved

    How the Roy Moore Sexual Misconduct Scandal Has Evolved

    Moore, while national party leaders said he should drop out of the race if the claims proved to be true. Jones has said little about them, content to let the story unfold without his input.
    Provas do Encceja acontecem neste domingo em dois períodos

    Provas do Encceja acontecem neste domingo em dois períodos

    Fuso Horário - Por causa do horário de verão, e dos diferentes fusos em vigor no Brasil, há quatro variações de horário. Já para o Ensino Médio, as áreas serão ciências da natureza e suas tecnologias e ciências humanas e suas tecnologias.
  • Analyst Consensus Recommendations on JPMorgan Chase & Co. (NYSE:JPM)

    Blair William Il stated it has 588,511 shares or 0.17% of all its holdings. 25 funds opened positions while 65 raised stakes. The financial services provider reported $1.76 EPS for the quarter, beating analysts' consensus estimates of $1.67 by $0.09.
    NC authorities cancel Amber Alert for 21-month-old

    NC authorities cancel Amber Alert for 21-month-old

    According to the alert, the child and suspect were last seen at the Westgate Terrace Apartments in Red Springs, North Carolina. Locklear is 5 foot 9 inches tall and weighs 160 pounds with brown hair and brown eyes.

    Coming Out Of Shadows? Entravision Communications Corporation (EVC), Accuray Incorporated (ARAY)

    Entravision Communications Corporation (NYSE: EVC ) closed up +0.25 points or 4.35% at $6 with 1.44 mln shares exchanging hands. Gotham Asset Management LLC acquired a new stake in Entravision Communications Corporation in the first quarter worth $158,000.
  • Northwestern beats Minnesota 39-0 for sixth-straight victory

    Northwestern beats Minnesota 39-0 for sixth-straight victory

    Two plays later, the Wildcats took a 19-0 lead following Jelani Roberts' 12-yard touchdown run, his only carry of the day. Minnesota (5-6, 2-6) was shut out just one week after its season-high scoring output, a 54-21 win over Nebraska .

    Violence against Muslims: 19 arrested in Sri Lanka after communal clashes

    One of those arrested was a woman who falsely spread news that Muslims were about to attack a Buddhist temple, he said. The community has been complaining of increasing attacks against them in recent years.
    Palestinians reject 'extortion' in face of U.S.  move: Foreign minister

    Palestinians reject 'extortion' in face of U.S. move: Foreign minister

    Malki said the USA move may be aimed at putting pressure on the Palestinians. Netanyahu's office says the closure is a "matter of US law".
  • Is Novavax, Inc. (NASDAQ:NVAX) A Safe Bet For Investors?

    The average investment rating for NVAX on a scale of 1 to 5 (1 being a strong sell and 5 being a strong buy) is a 3.57 or a Hold. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link .
    Top general says he would resist

    Top general says he would resist "illegal" nuke order from Trump

    If Trump chose to launch a nuclear attack, Hyten would provide him with strike options, and the president would make his decision. In a hearing earlier this week, Sen. " President Trump by himself can't change the behavior of Kim Jong Un", Hyten said.
    'True Detective': Carmen Ejogo to Star Opposite Mahershala Ali in Season 3

    'True Detective': Carmen Ejogo to Star Opposite Mahershala Ali in Season 3

    She now stars on the second season of the Starz series " The Girlfriend Experience " for writer and director Amy Seimetz. Ejogo will play Amelia Reardon, an Arkansas schoolteacher with a connection to two missing children in 1980.

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.